Methods of sedating a patient undergoing critical care treatment using intravenous gaboxadol or a pharmaceutically acceptable salt thereof are provided. Parenteral formulations for critical care sedation using intravenous gaboxadol or a pharmaceutically acceptable salt thereof are provided. The parenteral formulations are particularly well suited for use in critical care sedation.